ASSAYED, NOT ASSERTEDSee Sample COA->
PeptideSource B2B RESEARCH MATERIALS
Menu
CatalogPurchase ListQualityAbout
EN中文
WhatsApp supportLog inCreate account
← Back to catalog

peptide research material

BPC-157

Repair Peptides
BPC-157

Purchase options

BPC-157 purchase details

From $2.18/vial · In stock

Lowest published volume-tier equivalent. View pack prices and order tiers below.

Specifications3 SKUs

2mg*10vials

BPC-157-2MG-10VIALS

≥99%

$40.60Tier 1 / 10 vials

MOQ: 1 10 vials

Order T1$200+$40.60
Order T2$2,000+$30.45
Order T3$5,000+$24.87
Order T4$10,000+$21.82

Worldwide shipping to most destinations. Contact us on WhatsApp for special destinations.

Orders are normally prepared for dispatch the next business day. Contact us on WhatsApp for special handling or timing requirements.

Ask on WhatsAppEmail purchase supportHow it works? View a Sample Verification Page

BPC-157 is positioned by PeptideSource for qualified repair peptides sourcing rather than personal-use guidance. Buyers can verify CAS 137525-51-0, formula C62H98N16O22, 1419.5 Da molecular weight, then compare sku coverage includes 10mg*10vials · 2mg*10vials · 5mg*10vials, lead time, minimum order, and document availability. Review priorities include sequence or identity confirmation, repair-category SKU planning, and blend feasibility, plus ≥99% and batch-specific quality support.

Buyer fit

Who buys this, and why

BPC-157 is listed for qualified B2B buyers reviewing repair-category peptide sourcing and component-document review. Procurement teams should compare sequence identity, repair-category literature context, blend feasibility, and batch-file readiness while keeping the page focused on research-material sourcing rather than personal-use, dosing, treatment, or outcome guidance.

Category: Repair Peptides. Repair-focused peptides and blends for soft-tissue, tendon, GI mucosa, and recovery research.

Specifications

Procurement-ready product data

CAS
137525-51-0
Molecular formula
C62H98N16O22
Molecular weight
1419.5 Da
Appearance
Lyophilized powder or supplied format listed on batch COA
Purity / identity
≥99%
Common vial sizes
10mg*10vials · 2mg*10vials · 5mg*10vials
Storage
Store according to the batch COA and product handling note.

Batch Quality Verification

See how PeptideSource verifies a lot before document review.

Sample COA format, lot-code conventions, and the current-batch matching workflow are summarized below. Sample values are clearly marked as demo records; live HPLC/MS and release files are matched by QA.

Sample verification card

PS-BPC157-2606-006

Public demo page showing the PeptideSource COA format, QA status, and PDF access pattern.

Current batch request

Matched by SKU + lot ID

Live order documents are supplied after QA confirms the exact product, SKU, and available lot.

Example lot-code format

PS-BPC-2606-299

Format example only. Real batch IDs are assigned from production and release records.

QA review window

6-14 business hours

Typical document-matching window for qualified procurement requests, subject to current batch status.

Laboratory Planning Tool

Plan vial mass, volume, and inventory notes.

Open the calculator as a procurement planning aid for vial mass, diluent-volume records, and target concentration notes. It is not a human-use protocol, administration guide, or clinical recommendation.

Open laboratory calculator

Priority sourcing brief

BPC-157 sourcing brief for repair-peptide procurement

This repair peptides brief frames BPC-157 around supplier comparison and batch documentation. Identity fields include CAS 137525-51-0, formula C62H98N16O22, 1419.5 Da molecular weight. Quote review should cover the SKU ladder (10mg*10vials · 2mg*10vials · 5mg*10vials), ≥99%, COA/HPLC/MS/SDS availability, MOQ, lead time, and replenishment planning.

Compare category

Quick sourcing answer

Identity
CAS 137525-51-0; formula C62H98N16O22; molecular weight about 1419.5 Da; PubChem lists the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.
Procurement fit
Built for laboratories, distributors, and qualified sourcing teams comparing standalone BPC-157, repair-oriented blends, and OEM/private-label fill requirements.
Document review
Request current COA, HPLC chromatogram, MS identity support, SDS, storage notes, sequence context, salt or counter-ion notes when disclosed, and batch-specific label details.
SKU planning
Active catalog coverage includes 2 mg, 5 mg, and 10 mg x 10-vial options, with order-wide tier pricing and blend/OEM review handled separately.

Procurement checks

  • Confirm CAS 137525-51-0, formula C62H98N16O22, sequence context, molecular-weight reference, and current batch documentation.
  • Compare 2 mg, 5 mg, and 10 mg x 10-vial standalone SKUs with repair blends only from a sourcing and document standpoint.
  • Request COA, HPLC, MS, SDS, storage notes, counter-ion or salt context when disclosed, and label details for procurement records.
  • Clarify whether the buyer needs catalog supply, repeat distributor replenishment, private-label fill, or blend/OEM feasibility review.

Buyer comparison notes

Compared with TB-500
Buyers compare sequence identity, vial strength, batch files, blend requirements, SKU availability, and repeat-order document continuity.
Standalone vs blend
Review component identity, total fill, component ratio, document support, and local compliance requirements before ordering.
Search-intent handling
Oral, injectable, reconstitution, or dosing searches are treated as compliance-sensitive topics; sourcing review focuses on SKU, storage, and documentation.

Technical procurement review

Sequence identity and public-reference context

BPC-157 should be reviewed as a defined pentadecapeptide identity record rather than a generic repair-peptide label. Public PubChem data identifies the CAS record, C62H98N16O22 formula, approximate 1419.5 Da molecular weight, and the 15-residue sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Those fields help buyers orient the material, but quote approval should still rely on the current supplier batch packet, MS identity support, HPLC purity trace, and label details.

What buyers should compare before quote approval

A useful BPC-157 sourcing review connects sequence, documents, and commercial terms. Compare CAS 137525-51-0, sequence support, purity basis, vial size, net peptide content, HPLC purity, MS identity, residual-solvent or counter-ion notes when available, storage guidance, MOQ, lead time, and whether the same document standard can be repeated across future batches.

BPC-157 vs TB-500 and blend sourcing angle

BPC-157 is frequently compared with TB-500 and repair-oriented blends, but procurement teams should separate component identity from blend naming. A standalone BPC-157 quote should be checked by sequence, CAS, SKU, purity file, and batch label. Blend or OEM requests need a separate component-level review so the buyer can confirm total fill, component ratio, and whether each ingredient has matching COA/HPLC/MS support.

Salt form and batch-file continuity

Public database synonyms include free-base and trifluoroacetate-related wording, which is useful context but not a substitute for lot-specific disclosure. Buyers who require acetate exchange, low residual TFA, or other counter-ion constraints should request that detail before quote approval. For repeat orders, document continuity matters as much as the initial SKU price because downstream buyers often need the same batch-file standard for replenishment.

Public identity anchors

PubChem CID 9941957Public compound identity record for BPC-157, CAS, formula, and sequence synonyms.Europe PMC literature indexBiomedical literature index for BPC-157 research records.ChEMBL CHEMBL4297358Public EMBL-EBI molecule record connected to BPC-157 identity.

Request checklist

  • Current SKU size and fill target
  • COA, HPLC, MS, and SDS document needs
  • MOQ, order tier, and repeat-order estimate
  • Storage, transport, and destination-market requirements

Useful next pages

Repair peptides categoryCompare BPC-157, TB-500, ARA-290, and repair-oriented blends.Quality & COA supportCheck how document packets are requested and matched to batch context.Custom Blends & OEMReview custom fill, private-label, and blend sourcing paths.

Quality documentation

COA, HPLC, and MS support for this product.

Batch document coverage is summarized below. Qualified buyer packets are matched by product name, SKU, purchase-list item, and confirmed lot during QA review.

COA

Batch-specific certificate available for qualified buyer review.

HPLC

Purity documentation available for every product.

MS

Molecular identity confirmation available on request.

SDS

Safety and handling documents available for procurement review.

Document packet

Document coverage for qualified buyer review

COA

Batch-specific certificate of analysis for buyer review.

HPLC chromatogram

Purity chromatogram available for every product request.

Mass-spec identity

Identity support packet can be matched to the requested SKU.

Residual solvent / counter-ion

Provided when available or required for procurement review.

SDS / MSDS

Safety and handling document available for operational review.

Stability or release support

Shared when relevant to the requested batch or OEM workflow.

Molecular & Structure

CAS
137525-51-0
Molecular formula
C62H98N16O22
Molecular weight
1419.5

Research Evidence & Regulatory Notes

PeptideSource keeps public identity references and supplier-side documents attached to BPC-157 as sourcing support. Qualified buyers can request the current COA, HPLC chromatogram, MS identity support, SDS, storage guidance, and applicable batch context before quote approval.

Public Sources & References

Europe PMCeuropepmc.org · 5 recordsPubChempubchem.ncbi.nlm.nih.govProtective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury.Yıldırım AK, Demirtaş H, Özer A, Arslan M. · 2026 · Europe PMCStable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats.Grubisic MM, Strbe S, Barisic I, Balenovic D, Stambolija V, Lozic M, Ostojic SB, Oreskovic I, Zizek H, Brcic K, Coric L, Staresinic M, Blagaic V, Oreskovic LB, Halle ZB, Matek D, Soldo D, Grizelj B, Blagaic AB, Skrtic A, Seiwerth S, Sikiric P. · 2026 · Europe PMCEndothelium-Dependent Nitric Oxide-Mediated Vasorelaxant Effects of BPC 157 in Human Internal Mammary Artery.Yildirim AK, Dastan AO, Demeli Ertus M, Ensarioglu M, Karabacak K, Pehlivanoglu B. · 2026 · Europe PMCBPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase.Jelińska J, Józwiak M, Szeleszczuk Ł, Sikora K, Kamysz W, Kleczkowska P, Gackowski M, Grodner B. · 2026 · Europe PMCFrom Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management.Yuan C, Demers A, Silva-Ortiz V, Hasoon JJ, Lee W, Dave K, Amirdelfan K, Burke HW, Christo PJ, Robinson CL. · 2026 · Europe PMC

Buyer questions

Common sourcing questions

What makes BPC-157 different from a generic peptide listing?

BPC-157 is grouped for repair-category peptide sourcing and component-document review, so the useful procurement review includes sequence identity, repair-category literature context, blend feasibility, and batch-file readiness in addition to identity fields, SKU size, MOQ, and quote terms.

Which quality documents can be requested for BPC-157?

Qualified buyers can request COA, HPLC purity support, MS identity context, SDS, storage notes, and batch-specific information when available for the quoted SKU.

How should buyers compare BPC-157 before approving a quote?

Compare identity fields, category-specific review points, purity basis, SKU size, MOQ, lead time, tier pricing, storage expectations, and document packet readiness.

Does this page provide use instructions for BPC-157?

No. The page is written for qualified B2B research-material sourcing, supplier evaluation, and document review only.

Can PeptideSource support bulk or repeat-order review for BPC-157?

Yes. Buyers can share target SKU sizes, quantity expectations, document requirements, destination needs, and repeat-order plans for B2B quote review.

Which identity fields define BPC-157 for PeptideSource sourcing review?

BPC-157 is reviewed against CAS 137525-51-0, formula C62H98N16O22, 1419.5 Da. The next check is the current batch packet, including COA, HPLC chromatogram, MS or identity support, and any label or storage notes needed for a procurement file.

How should BPC-157 searches around cas 137525-51-0, formula, and sequence identity review be used for sourcing?

CAS 137525-51-0, formula, and sequence identity review is treated as search context, not as a protocol or outcome claim. PeptideSource people usually check CAS 137525-51-0, formula C62H98N16O22, 1419.5 Da, SKU coverage such as 10mg*10vials, purity basis, COA/HPLC/MS support, storage notes, and batch-document availability before comparing suppliers.

How should BPC-157 searches around coa, hplc/ms, salt form, and blend document review be used for sourcing?

COA, HPLC/MS, salt form, and blend document review is treated as search context, not as a protocol or outcome claim. PeptideSource people usually check CAS 137525-51-0, formula C62H98N16O22, 1419.5 Da, SKU coverage such as 10mg*10vials, purity basis, COA/HPLC/MS support, storage notes, and batch-document availability before comparing suppliers.

How does PeptideSource handle COA, HPLC, and MS requests for BPC-157?

Send the product name, SKU, or intended purchase-list line and the support team will match available COA, HPLC chromatogram, MS identity support, SDS, storage notes, and related batch context. Documents are shared for qualified buyer, sourcing, and procurement review.

How should BPC-157 SKU size and fill options be scoped?

BPC-157 has catalog coverage that includes 10mg*10vials. Buyers should compare the full SKU ladder, minimum order, sales unit, and order-wide tier pricing before deciding whether catalog supply, bulk replenishment, or custom fill review is needed.

How should oral, injectable, or blend searches around BPC-157 be interpreted?

Those terms are useful for understanding search demand, but they are not use directions. The sourcing file should focus on SKU size, purity, sequence or identity data, COA/HPLC/MS support, and whether the request is for a single material, catalog blend, or OEM review.

Can BPC-157 be compared with BPC-157, TB-500, or nearby repair materials?

Yes, as a sourcing comparison. Useful fields include sequence or identity data, purity documentation, vial size, minimum order, price tier, component requirements for blends, and document-packet availability.

Research Center

Procurement comparison and document guides

View all guides
Supplier evaluationWhere to Buy Research Peptides with COA DocumentationStorage reviewPeptide Stability and Storage Guidelines for Research ProcurementCOA reviewHow to Read a Peptide COA for B2B Research Sourcing

Technical Library

Long-form quality and sourcing context

View library
Quality documentationPeptide Purity Grades Explained: HPLC vs. Prep-HPLCStability and storageHow to Store Research Peptides: Stability GuideSupplier auditFinding a GMP Peptide Supplier: Checklist for B2B Buyers

Related products

More in Repair Peptides

Browse category
TB-500885340-08-9TB500TB-500BPC-157 + TB-500 10mg+10mgRepair Peptides